Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

• Amanda Mocroft ,

  * E-mail: a.mocroft@ucl.ac.uk

  Affiliation Department of Infection and Population Health, University College London, London, United Kingdom

  ⨯
• Jens D. Lundgren,

  Affiliation Copenhagen HIV Programme, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Michael Ross,

  Affiliation Division of Nephrology, Mount Sinai School of Medicine, New York, New York, United States of America

  ⨯
• Matthew Law,

  Affiliation The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia

  ⨯
• Peter Reiss,

  Affiliation Division of Infectious Diseases and Department of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

  ⨯
• Ole Kirk,

  Affiliation Copenhagen HIV Programme, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Colette Smith,

  Affiliation Department of Infection and Population Health, University College London, London, United Kingdom

  ⨯
• Deborah Wentworth,

  Affiliation University of Minnesota, Minneapolis, Minnesota, United States of America

  ⨯
• Jacqueline Neuhaus,

  Affiliation University of Minnesota, Minneapolis, Minnesota, United States of America

  ⨯
• Christoph A. Fux,

  Affiliation Clinic for Infectious Diseases and Hospital Hygiene, Kantonsspital Aarau, Aarau, Switzerland

  ⨯
• Olivier Moranne,

  Affiliation Nephrology Department, Public Health Department, Centre Hospitalier Universitaire de Nice, Nice, France

  ⨯
• Phillipe Morlat,

  Affiliation Université de Bordeaux, INSERM U 897, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France

  ⨯
• Margaret A. Johnson,

  Affiliation Department of HIV Medicine, Royal Free London NHS Foundation Trust, London, United Kingdom

  ⨯
• Lene Ryom,

  Affiliation Copenhagen HIV Programme, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

  ⨯
• D:A:D study group, the Royal Free Hospital Clinic Cohort, and the INSIGHT, SMART, and ESPRIT study groups

  ¶Membership of the D:A:D study group, the Royal Free Hospital Clinic Cohort, and the INSIGHT, SMART, and ESPRIT study groups is listed in the Acknowledgments.

  ⨯